SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-12-03 16:40
Tx date 2025-12-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,430 vol 		230,450
Filed 2025-11-06 17:55
Tx date 2025-11-03 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,430 vol 		228,020
Filed 2025-10-02 08:57
Tx date 2025-10-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,430 vol 		225,590
Filed 2025-09-04 07:35
Tx date 2025-09-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,431 vol 		223,160
Filed 2025-08-04 10:55
Tx date 2025-08-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,431 vol 		220,729
Filed 2025-07-02 09:01
Tx date 2025-07-01 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,431 vol 		218,298
Filed 2025-06-04 13:07
Tx date 2025-06-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$41,922
+8,220 vol
$5.10 each 		215,867
Filed 2025-06-04 13:05
Tx date 2025-06-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market 		$-41,922
-8,220 vol
$5.10 each 		805,964
Filed 2025-06-04 13:03
Tx date 2025-06-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+2,431 vol 		207,647
Filed 2025-05-19 17:43
Tx date 2025-05-16 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+16,667 vol 		205,216
Filed 2025-05-01 08:55
Tx date 2025-04-30 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		188,549
Filed 2025-04-03 12:27
Tx date 2025-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$325,000
+50,000 vol
$6.50 each 		814,184
Filed 2025-04-03 12:21
Tx date 2025-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$487,500
+75,000 vol
$6.50 each
Filed 2025-04-03 12:18
Tx date 2025-03-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		187,507
Filed 2025-03-04 16:50
Tx date 2025-02-28 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		186,465
Filed 2025-02-05 16:49
Tx date 2025-01-31 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		185,423
Filed 2025-01-06 09:50
Tx date 2025-01-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		184,381
Filed 2024-12-05 17:19
Tx date 2024-12-02 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
+1,042 vol 		183,339
Filed 2024-11-21 10:34
Tx date 2024-11-18 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$38,749
+15,816 vol
$2.45 each 		182,297
Filed 2024-11-21 10:33
Tx date 2024-11-18 		$FRX
Fennec Pharmaceuticals Inc. 		Andrade, Robert Christopher
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-38,749.20
-15,816 vol
$2.45 each 		764,184